Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells

BACKGROUND: AZD3514 inhibits and down regulates the androgen receptor (AR) and has undergone clinical trials in prostate cancer. To provide proof-of-mechanism (POM) in patients, an immunohistochemistry (IHC) method for determination of AR in circulating tumour cells (CTC) was developed and validated...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Cummings, Jeffrey, Sloane, Robert, Morris, Karen, Zhou, Cong, Lancashire, Matt, Moore, David, Elliot, Tony, Clarke, Noel, Dive, Caroline
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Technical Advance
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977890/
https://ncbi.nlm.nih.gov/pubmed/24674711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-226
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы